Physician
Lawler, Sharon
Lawler, Sharon was paid $269K by Medicaid between Jan 2018 and Sep 2024, across 31 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 66% of everything it billed.
33Billing provider infoLAWLER, SHARON
HONOLULU, HI 96816
HONOLULU, HI 96816
33aNPI1346297926assigned 05/28/2006
33bProvider typeInternal Medicine Physician
28Total paid$269K
24GClaims25,684
24DCodes billed31
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other Internal Medicine Physician providers in Hawaii
Rank by total paid#14 of 123
Median peer was paid$27K
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,186 | $46K | |
| 2019 | 6,776 | $61K | |
| 2020 | 3,834 | $39K | |
| 2021 | 2,433 | $30K | |
| 2022 | 3,246 | $38K | |
| 2023 | 2,800 | $40K | |
| 2024incomplete | 409 | $15K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 66% | 12,015 | 6,871 | $178K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 1,912 | 1,209 | $58K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 11% | 2,641 | 661 | $29K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 239 | 72 | $2K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 80 | 16 | $781.88 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 64 | 13 | $313.55 |
| 96127 | <1% | 232 | 220 | $291.60 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 145 | 40 | $283.79 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 28 | 12 | $241.96 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 44 | 26 | $175.56 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 121 | 62 | $136.62 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 18 | 12 | $98.06 |
19 more codes
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 86 | $29.54 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 89 | $16.94 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 28 | $16.06 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 33 | $11.87 |
| 3074F | <1% | 1,536 | $2.52 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 73 | $1.87 |
| 3079F | <1% | 897 | $1.58 | |
| 3078F | <1% | 1,599 | $1.48 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 12 | $1.00 |
| 3075F | <1% | 799 | $0.42 | |
| 3044F | <1% | 247 | $0.16 | |
| 1036F | <1% | 1,977 | $0.04 | |
| 3077F | <1% | 111 | $0.03 | |
| 1159F | <1% | 35 | $0.02 | |
| 1160F | <1% | 35 | $0.02 | |
| 1158F | 0% | 21 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 511 | $0.00 |
| 1157F | 0% | 12 | $0.00 | |
| 3080F | 0% | 44 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.